RIM
PFE icon

Reynolds Investment Management’s Pfizer PFE Stock Holding History

Reynolds Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$2.06M Sell
39,277
-2,144
-5% -$109K 0.73% 36
2022
Q1 		$2.14M Buy
+41,421
New +$2.15M 0.63% 40

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Reynolds Investment Management's PFE Position: Q2 2022 in Review

Reynolds Investment Management reduced its Pfizer (PFE) stake by 5.2% in Q2 2022, selling an estimated $109K and leaving 39,277 shares worth $2.06M. The position accounts for 0.73% of the portfolio, ranked #36.

Reynolds Investment Management first reported a position in PFE in Q1 2022 and has held it in 2 quarters since. The position peaked at $2.14M in Q1 2022. 3,157 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • Reynolds Investment Management held 39,277 shares of Pfizer worth $2.06M as of Q2 2022.
  • Reynolds Investment Management sold 2,144 Pfizer shares in Q2 2022, an estimated $109K.
  • Pfizer made up 0.73% of Reynolds Investment Management's portfolio in Q2 2022, its #36 holding.
  • Reynolds Investment Management first reported a position in Pfizer in Q1 2022 and has held it in 2 quarters since.
  • Reynolds Investment Management's Pfizer position peaked at $2.14M in Q1 2022.
  • 3,157 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on Reynolds Investment Management's 13F filing for Q2 2022, filed 27 Jul 2022.